Iovance Biotherapeutics Inc (IOVA)

Finanzdaten der Iovance Biotherapeutics Inc-Aktie (IOVA)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	2.77% 0.482	0.469	0.238	-	-
Cost Of Revenue	0.58% 4.365	4.34	2.05	-	-
Gross Profit	0.31% -3.883	-3.871	-1.812	-	-
Operating Expenses	2.52% 117.37	114.49	108.27	110.86	107.04
Benefits Costs and Expenses	2.73% 118.62	115.47	107.24	107.37	-
Costs And Expenses	2.45% 121.74	118.83	110.32	110.86	-
Operating Income/Loss	2.45% -121.26	-118.36	-110.09	-110.86	-107.04
Income/Loss From Continuing Operations Before Tax	2.73% -118.14	-115.00	-107.00	-107.37	-105.32
Income Tax Expense/Benefit, Deferred	41.51% -1.759	-1.243	-	-	-
Income Tax Expense/Benefit	41.51% -1.759	-1.243	-0.477	-	-
Income/Loss From Continuing Operations After Tax	2.30% -116.38	-113.76	-106.53	-107.37	-105.32
Net Income/Loss	2.30% -116.38	-113.76	-106.53	-107.37	-105.32
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	192.70% -227.88	245.82	224.48	213.69	-157.24
Diluted Average Shares	192.70% -227.88	245.82	224.48	213.69	-157.24
Basic Earnings Per Share	2.17% -0.45	-0.46	-0.47	-0.50	-0.64
Diluted Earnings Per Share	2.17% -0.45	-0.46	-0.47	-0.50	-0.64
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-